about
Metformin-associated prevention of weight gain in insulin-treated type 2 diabetic patients cannot be explained by decreased energy intake: A post hoc analysis of a randomized placebo-controlled 4.3-year trial.Metformin and β-cell function in insulin-treated patients with type 2 diabetes: A randomized placebo-controlled 4.3-year trial.Long-term treatment with metformin in type 2 diabetes and vitamin D levels: A post-hoc analysis of a randomized placebo-controlled trialHow representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study
P50
description
researcher
@en
wetenschapper
@nl
name
Adriaan Kooy
@en
Adriaan Kooy
@nl
type
label
Adriaan Kooy
@en
Adriaan Kooy
@nl
prefLabel
Adriaan Kooy
@en
Adriaan Kooy
@nl
P31
P496
0000-0002-8853-0019